Tumor necrosis factor-α:: is there a continuum of liability between stress, anxiety states and anorexia nervosa?

被引:35
作者
Holden, RJ
Pakula, IS
机构
[1] Univ Wollongong, Med Res Unit, Wollongong, NSW 2522, Australia
[2] Illawarra Area Hlth Serv, Psychiat Serv, Shellharbour Sq, NSW, Australia
关键词
D O I
10.1054/mehy.1997.0641
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Since the time of Freud, psychiatry has embraced the proposition that physiological and/or psychological stress precipitates various psychiatric disorders. To this effect, we propose that a continuum of liability obtains between stress, anxiety states and anorexia nervosa - a continuum which is grounded on a cytokine profile common to each of these conditions. For example, the biological response to stress, anxiety states and anorexia nervosa includes the elevation of interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha), and downregulation of interferon-gamma (IFN-gamma). Sustained elevation of IL-1 beta and TNF-alpha dysregulates both somatostatin and insulin secretion, the tatter of which influences regional cerebral blood flow (rCBF) and brain energy metabolism. In addition, IL-1 beta and TNF-alpha influence the expression of certain crucial neuropeptides, which are known to be associated with anxiety states and anorexia nervosa. These neuropeptides include: beta-endorphin, cholecystokinin (CCK), neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP). beta-endorphin effects glucose metabolism in the limbic system, CCK increases the release of beta-endorphin from the anterior pituitary, NPY is a powerful anxiolytic that regulates beta-endorphin and insulin, while VIP indirectly regulates the expression of TNF-alpha through the inhibition of interleukin-4 (IL-4).
引用
收藏
页码:155 / 162
页数:8
相关论文
共 84 条
  • [1] ABLEITNER A, 1992, J PHARMACOL EXP THER, V262, P415
  • [2] Abraham E, 1991, Methods Achiev Exp Pathol, V14, P45
  • [3] STRESS-TRIGGERED ABORTION - INHIBITION OF PROTECTIVE SUPPRESSION AND PROMOTION OF TUMOR NECROSIS FACTOR-ALPHA(TNF-ALPHA) RELEASE AS A MECHANISM TRIGGERING RESORPTIONS IN MICE
    ARCK, PC
    MERALI, FS
    MANUEL, J
    CHAOUAT, G
    CLARK, DA
    [J]. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1995, 33 (01): : 74 - 80
  • [4] ARIAS J, 1992, TRANSPLANT P, V24, P2909
  • [5] CHARACTERIZATION OF DIFFERENTIATION FACTOR LEUKEMIA INHIBITORY FACTOR EFFECT ON LIPOPROTEIN-LIPASE ACTIVITY AND MESSENGER-RNA IN 3T3-L1 ADIPOCYTES
    BERG, M
    FRAKER, DL
    ALEXANDER, HR
    [J]. CYTOKINE, 1994, 6 (04) : 425 - 432
  • [6] CYTOKINE PRODUCTION IN ANOREXIA-NERVOSA
    BESSLER, H
    KARP, L
    NOTTI, I
    APTER, A
    TYANO, S
    DJALDETTI, M
    WEIZMAN, R
    [J]. CLINICAL NEUROPHARMACOLOGY, 1993, 16 (03) : 237 - 243
  • [7] CSF OPIOIDS IN PANIC DISORDER
    BRADY, KT
    LYDIARD, RB
    BALLENGER, JC
    SHOOK, J
    LARAIA, M
    FOSSEY, M
    [J]. BIOLOGICAL PSYCHIATRY, 1991, 30 (05) : 512 - 514
  • [8] PLASMA INTERLEUKIN-1-BETA CONCENTRATIONS IN PANIC DISORDER
    BRAMBILLA, F
    BELLODI, L
    PERNA, G
    BERTANI, A
    PANERAI, A
    SACERDOTE, P
    [J]. PSYCHIATRY RESEARCH, 1994, 54 (02) : 135 - 142
  • [9] IMMUNOLOGICAL ANALYSIS OF GLUCOSE TRANSPORTERS EXPRESSED IN DIFFERENT REGIONS OF THE RAT-BRAIN AND CENTRAL-NERVOUS-SYSTEM
    BRANT, AM
    JESS, TJ
    MILLIGAN, G
    BROWN, CM
    GOULD, GW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (03) : 1297 - 1302
  • [10] CARR DJJ, 1991, P SOC EXP BIOL MED, V198, P710